Millipore Sigma Vibrant Logo

219369 Carcinoembryonic Antigen, Human Colon Adenocarcinoma Cell Line

View Products on Sigmaaldrich.com
219369
Ver precios y disponibilidad

Descripción

Replacement Information

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
219369-100UG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ampolla de plást. 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      Description
      OverviewNative CEA from human colon adenocarcinoma cells. Found in tumors in adults. Presence indicates carcinogenic activity. Purified CEA has been the most widely-used general marker in determining and monitoring the status of malignant disease.
      Catalogue Number219369
      Brand Family Calbiochem®
      SynonymsCEA
      References
      ReferencesNomoto, K., et al. 1998. Jpn. J. Cancer Res. 89, 1257.
      Jacobs, E.L., and Haskell, C.M. 1991. Curr. Probl. Cancer 15, 299.
      Robertson, J.F., et al. 1991. Br. J. Cancer 64, 757.
      Product Information
      FormLyophilized
      Quality LevelMQ100
      Applications
      Biological Information
      Puritysingle diffuse band by SDS-PAGE
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      219369-100UG 07790788048662

      Documentation

      Carcinoembryonic Antigen, Human Colon Adenocarcinoma Cell Line Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Carcinoembryonic Antigen, Human Colon Adenocarcinoma Cell Line Certificados de análisis

      CargoNúmero de lote
      219369

      Referencias bibliográficas

      Visión general referencias
      Nomoto, K., et al. 1998. Jpn. J. Cancer Res. 89, 1257.
      Jacobs, E.L., and Haskell, C.M. 1991. Curr. Probl. Cancer 15, 299.
      Robertson, J.F., et al. 1991. Br. J. Cancer 64, 757.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-June-2008 RFH
      SynonymsCEA
      DescriptionNative CEA from human colon adenocarcinoma cells. Found in tumors in adults. Widely used cancer marker found on many adult tumors. For more than a decade, purified CEA has been the most widely used general marker in determining and monitoring the status of malignant disease. This preparation is derived from an established adenocarcinoma cell line.
      FormLyophilized
      Puritysingle diffuse band by SDS-PAGE
      SolubilityAqueous Buffers
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesNomoto, K., et al. 1998. Jpn. J. Cancer Res. 89, 1257.
      Jacobs, E.L., and Haskell, C.M. 1991. Curr. Probl. Cancer 15, 299.
      Robertson, J.F., et al. 1991. Br. J. Cancer 64, 757.